SEV-41685-10537
5 vaccinations
1 coded response
56 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 170 / PA
- Registered
- 2021-02-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-13
Dose 1 — Pfizer-BioNTech
-
2021-02-14
Registered in v-safe
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-27
-
2021-03-06
Dose 2 — Pfizer-BioNTech
- 2021-03-20
- 2021-03-27
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-06-05
- 2021-09-04
-
2021-10-01
Dose 3 — Pfizer-BioNTech
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness · Fatigue or tirednessAdult check-in
-
2021-10-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
-
2021-10-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2021-12-31
- 2022-04-01
-
2022-07-19
Dose 4 — Pfizer-BioNTech
-
2022-07-19
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2022-07-20
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-08-02
- 2022-08-09
- 2022-08-16
- 2022-08-23
-
2022-08-30
Survey response — day 42, dose 4MedDRA: Unevaluable event — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Gallbladder attacks, possibly.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-30
Report sent to call center — day 42, dose 4Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-01
-
2022-10-08
Dose 5 — Pfizer-BioNTechCo-administered: Flu
-
2022-10-09
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-13
- 2022-10-14
- 2022-10-15
- 2022-10-22
- 2022-10-29
- 2022-11-07
- 2022-11-12
- 2022-11-19
- 2023-01-07
- 2023-04-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-13 | Pfizer-BioNTech | |
| 2 | 2021-03-06 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | No |
| 4 | 2022-07-19 | Pfizer-BioNTech | No |
| 5 | 2022-10-08 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — day 42, dose 4
Symptoms: Gallbladder attacks, possibly.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Unevaluable event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release